44.300
USD
0.16
(0.36%)
Market Open
Last updated: · Delayed 15 min
Fair value62.64Plus-29%47Price 44.3078
Q4 FY2026 · Earnings report
EPS estimate 0.78Revenue estimate 5.18B
Q4 FY2026 · Earnings report
EPS estimate 0.78Revenue estimate 5.18B
Boston Scientific debt to equity ratioWhat is the debt to equity ratio? Debt to equity is a company's total debt divided by its shareholders' equity: how much it has borrowed for each dollar its owners have in the business.
Boston Scientific's debt to equity ratio is 0.47: total debt of 11.95B USD against shareholders' equity of 25.63B USD.
- Today
- 0.47
- Average, 5 years
- 0.52
- Low, 5 years
- 0.43
- High, 5 years
- 0.58
Debt to equity = total debt ÷ shareholders' equity = 11.95B ÷ 25.63B = 0.47
Debt to equity
Total debt
Shareholders' equity
Total debt over shareholders' equity at each quarter end.
Debt to equity by year and by quarter
| Fiscal year | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Today | 0.47 | 11.95B | 25.63B | |
| FY2025 | 31 Dec 2025 | 0.49 | 11.85B | 24.23B |
| FY2024 | 31 Dec 2024 | 0.51 | 11.15B | 21.77B |
| FY2023 | 31 Dec 2023 | 0.49 | 9.49B | 19.28B |
| FY2022 | 31 Dec 2022 | 0.53 | 9.28B | 17.57B |
| FY2021 | 31 Dec 2021 | 0.57 | 9.45B | 16.62B |
| FY2020 | 31 Dec 2020 | 0.62 | 9.54B | 15.33B |
| FY2019 | 31 Dec 2019 | 0.74 | 10.28B | 13.88B |
| FY2018 | 31 Dec 2018 | 0.81 | 7.03B | 8.73B |
| FY2017 | 31 Dec 2017 | 0.80 | 5.58B | 7.01B |
| FY2016 | 31 Dec 2016 | 0.81 | 5.48B | 6.73B |
| FY2015 | 31 Dec 2015 | 0.90 | 5.68B | 6.32B |
| FY2014 | 31 Dec 2014 | 0.62 | 4.26B | 6.84B |
| FY2013 | 31 Dec 2013 | 0.65 | 4.24B | 6.54B |
| FY2012 | 31 Dec 2012 | 0.62 | 4.26B | 6.87B |
| FY2011 | 31 Dec 2011 | 0.38 | 4.26B | 11.35B |
| FY2010 | 31 Dec 2010 | 0.48 | 5.44B | 11.30B |
| FY2009 | 31 Dec 2009 | 0.48 | 5.92B | 12.30B |
| FY2008 | 31 Dec 2008 | 0.51 | 6.75B | 13.14B |
| FY2007 | 31 Dec 2007 | 0.54 | 8.19B | 15.10B |
| FY2006 | 31 Dec 2006 | 0.58 | 8.90B | 15.30B |
| FY2005 | 31 Dec 2005 | 0.47 | 2.02B | 4.28B |
| FY2004 | 31 Dec 2004 | 0.59 | 2.37B | 4.03B |
| FY2003 | 31 Dec 2003 | 0.60 | 1.73B | 2.86B |
| FY2002 | 31 Dec 2002 | 0.38 | 935.00M | 2.47B |
| FY2001 | 31 Dec 2001 | 0.60 | 1.20B | 2.02B |
| FY2000 | 31 Dec 2000 | 0.43 | 834.00M | 1.94B |
| FY1999 | 31 Dec 1999 | 0.74 | 1.28B | 1.72B |
| FY1998 | 31 Dec 1998 | 2.91 | 2.39B | 821.10M |
| FY1997 | 31 Dec 1997 | 0.50 | 493.50M | 986.20M |
| FY1996 | 31 Dec 1996 | 0.31 | 287.80M | 916.30M |
| FY1995 | 31 Dec 1995 | 0.09 | 71.00M | 753.00M |
| FY1994 | 31 Dec 1994 | 0.13 | 43.10M | 340.00M |
| FY1993 | 31 Dec 1993 | 0.14 | 35.50M | 246.70M |
| FY1992 | 31 Dec 1992 | 0.10 | 26.10M | 249.10M |
| FY1991 | 31 Dec 1991 | 0.28 | 25.20M | 90.30M |
| Quarter | Period ending | Debt to equity | Total debt | Shareholders' equity |
|---|---|---|---|---|
| Q3 FY2026 | 30 Sept 2026 | 0.47 | 11.95B | 25.63B |
| Q2 FY2026 | 30 Jun 2026 | 0.51 | 12.62B | 24.93B |
| Q1 FY2026 | 31 Mar 2026 | 0.43 | 11.03B | 25.86B |
| Q4 FY2025 | 31 Dec 2025 | 0.49 | 11.85B | 24.23B |
| Q3 FY2025 | 30 Sept 2025 | 0.51 | 12.05B | 23.40B |
| Q2 FY2025 | 30 Jun 2025 | 0.54 | 12.03B | 22.42B |
| Q1 FY2025 | 31 Mar 2025 | 0.53 | 11.71B | 22.21B |
| Q4 FY2024 | 31 Dec 2024 | 0.51 | 11.15B | 21.77B |
| Q3 FY2024 | 30 Sept 2024 | 0.54 | 11.26B | 20.71B |
| Q2 FY2024 | 30 Jun 2024 | 0.54 | 10.94B | 20.37B |
| Q1 FY2024 | 31 Mar 2024 | 0.55 | 11.00B | 19.93B |
| Q4 FY2023 | 31 Dec 2023 | 0.49 | 9.49B | 19.28B |
| Q3 FY2023 | 30 Sept 2023 | 0.49 | 9.30B | 18.89B |
| Q2 FY2023 | 30 Jun 2023 | 0.52 | 9.45B | 18.23B |
| Q1 FY2023 | 31 Mar 2023 | 0.52 | 9.37B | 17.85B |
| Q4 FY2022 | 31 Dec 2022 | 0.53 | 9.28B | 17.57B |
| Q3 FY2022 | 30 Sept 2022 | 0.51 | 8.93B | 17.64B |
| Q2 FY2022 | 30 Jun 2022 | 0.54 | 9.33B | 17.25B |
| Q1 FY2022 | 31 Mar 2022 | 0.58 | 9.68B | 16.74B |
| Q4 FY2021 | 31 Dec 2021 | 0.57 | 9.45B | 16.62B |
| Q3 FY2021 | 30 Sept 2021 | 0.57 | 9.46B | 16.46B |
| Q2 FY2021 | 30 Jun 2021 | 0.59 | 9.46B | 15.94B |
| Q1 FY2021 | 31 Mar 2021 | 0.60 | 9.44B | 15.72B |
| Q4 FY2020 | 31 Dec 2020 | 0.62 | 9.54B | 15.33B |
| Q3 FY2020 | 30 Sept 2020 | 0.60 | 9.33B | 15.56B |
| Q2 FY2020 | 30 Jun 2020 | 0.63 | 9.79B | 15.62B |
| Q1 FY2020 | 31 Mar 2020 | 0.77 | 10.60B | 13.80B |
| Q4 FY2019 | 31 Dec 2019 | 0.74 | 10.28B | 13.88B |
| Q3 FY2019 | 30 Sept 2019 | 1.12 | 10.87B | 9.70B |
| Q2 FY2019 | 30 Jun 2019 | 1.01 | 9.53B | 9.42B |
| Q1 FY2019 | 31 Mar 2019 | 1.00 | 9.21B | 9.23B |
| Q4 FY2018 | 31 Dec 2018 | 0.81 | 7.03B | 8.73B |
| Q3 FY2018 | 30 Sept 2018 | 0.80 | 6.60B | 8.29B |
| Q2 FY2018 | 30 Jun 2018 | 0.83 | 6.46B | 7.74B |
| Q1 FY2018 | 31 Mar 2018 | 0.82 | 5.73B | 7.03B |
| Q4 FY2017 | 31 Dec 2017 | 0.80 | 5.58B | 7.01B |
| Q3 FY2017 | 30 Sept 2017 | 0.75 | 5.68B | 7.59B |
| Q2 FY2017 | 30 Jun 2017 | 0.81 | 5.84B | 7.24B |
| Q1 FY2017 | 31 Mar 2017 | 0.78 | 5.51B | 7.05B |
| Q4 FY2016 | 31 Dec 2016 | 0.81 | 5.48B | 6.73B |
| Q3 FY2016 | 30 Sept 2016 | 0.84 | 5.43B | 6.48B |
| Q2 FY2016 | 30 Jun 2016 | 0.87 | 5.43B | 6.22B |
| Q1 FY2016 | 31 Mar 2016 | 0.88 | 5.68B | 6.46B |
| Q4 FY2015 | 31 Dec 2015 | 0.90 | 5.68B | 6.32B |
| Q3 FY2015 | 30 Sept 2015 | 0.91 | 5.86B | 6.41B |
| Q2 FY2015 | 30 Jun 2015 | 0.78 | 5.11B | 6.58B |
| Q1 FY2015 | 31 Mar 2015 | 0.66 | 4.27B | 6.50B |
| Q4 FY2014 | 31 Dec 2014 | 0.62 | 4.26B | 6.84B |
| Q3 FY2014 | 30 Sept 2014 | 0.63 | 4.25B | 6.70B |
| Q2 FY2014 | 30 Jun 2014 | 0.65 | 4.26B | 6.54B |
| Q1 FY2014 | 31 Mar 2014 | 0.65 | 4.25B | 6.53B |
| Q4 FY2013 | 31 Dec 2013 | 0.65 | 4.24B | 6.54B |
| Q3 FY2013 | 30 Sept 2013 | 0.65 | 4.25B | 6.56B |
| Q2 FY2013 | 30 Jun 2013 | 0.64 | 4.25B | 6.60B |
| Q1 FY2013 | 31 Mar 2013 | 0.65 | 4.25B | 6.50B |
| Q4 FY2012 | 31 Dec 2012 | 0.62 | 4.26B | 6.87B |
| Q3 FY2012 | 30 Sept 2012 | 0.63 | 4.26B | 6.77B |
| Q2 FY2012 | 30 Jun 2012 | 0.54 | 4.26B | 7.90B |
| Q1 FY2012 | 31 Mar 2012 | 0.37 | 4.26B | 11.40B |
| Q4 FY2011 | 31 Dec 2011 | 0.38 | 4.26B | 11.35B |
| Q3 FY2011 | 30 Sept 2011 | 0.37 | 4.26B | 11.52B |
| Q2 FY2011 | 30 Jun 2011 | 0.36 | 4.20B | 11.54B |
| Q1 FY2011 | 31 Mar 2011 | 0.43 | 4.92B | 11.34B |
| Q4 FY2010 | 31 Dec 2010 | 0.48 | 5.44B | 11.30B |
| Q3 FY2010 | 30 Sept 2010 | 0.55 | 6.04B | 11.04B |
| Q2 FY2010 | 30 Jun 2010 | 0.55 | 6.03B | 10.89B |
| Q1 FY2010 | 31 Mar 2010 | 0.55 | 5.92B | 10.78B |
| Q4 FY2009 | 31 Dec 2009 | 0.48 | 5.92B | 12.30B |
| Q3 FY2009 | 30 Sept 2009 | 0.44 | 6.03B | 13.59B |
| Q2 FY2009 | 30 Jun 2009 | 0.47 | 6.25B | 13.41B |
| Q1 FY2009 | 31 Mar 2009 | 0.47 | 6.25B | 13.28B |
| Q4 FY2008 | 31 Dec 2008 | 0.51 | 6.75B | 13.17B |
| Q3 FY2008 | 30 Sept 2008 | 0.45 | 7.00B | 15.69B |
| Q2 FY2008 | 30 Jun 2008 | 0.47 | 7.29B | 15.64B |
| Q1 FY2008 | 31 Mar 2008 | 0.49 | 7.57B | 15.39B |
| Q4 FY2007 | 31 Dec 2007 | 0.54 | 8.19B | 15.10B |
| Q3 FY2007 | 30 Sept 2007 | 0.53 | 8.16B | 15.52B |
| Q2 FY2007 | 30 Jun 2007 | 0.56 | 8.90B | 15.80B |
| Q1 FY2007 | 31 Mar 2007 | 0.57 | 8.91B | 15.55B |
| Q4 FY2006 | 31 Dec 2006 | 0.58 | 8.90B | 15.30B |
| Q3 FY2006 | 30 Sept 2006 | 0.59 | 8.90B | 15.02B |
| Q2 FY2006 | 30 Jun 2006 | 0.60 | 8.90B | 14.89B |
| Q1 FY2006 | 31 Mar 2006 | 0.57 | 2.64B | 4.67B |
| Q4 FY2005 | 31 Dec 2005 | 0.47 | 2.02B | 4.28B |
| Q3 FY2005 | 30 Sept 2005 | 0.64 | 2.51B | 3.90B |
| Q2 FY2005 | 30 Jun 2005 | 0.49 | 2.06B | 4.22B |
| Q1 FY2005 | 31 Mar 2005 | 0.35 | 1.55B | 4.39B |
| Q4 FY2004 | 31 Dec 2004 | 0.59 | 2.37B | 4.03B |
| Q3 FY2004 | 30 Sept 2004 | 0.62 | 2.50B | 4.01B |
| Q2 FY2004 | 30 Jun 2004 | 0.69 | 2.55B | 3.70B |
| Q1 FY2004 | 31 Mar 2004 | 0.52 | 1.68B | 3.22B |
| Q4 FY2003 | 31 Dec 2003 | 0.60 | 1.73B | 2.86B |
| Q3 FY2003 | 30 Sept 2003 | 0.64 | 1.64B | 2.58B |
| Q2 FY2003 | 30 Jun 2003 | 0.50 | 1.33B | 2.65B |
| Q1 FY2003 | 31 Mar 2003 | 0.51 | 1.25B | 2.48B |
| Q4 FY2002 | 31 Dec 2002 | 0.38 | 935.00M | 2.47B |
| Q3 FY2002 | 30 Sept 2002 | 0.48 | 1.11B | 2.29B |
| Q2 FY2002 | 30 Jun 2002 | 0.56 | 1.17B | 2.10B |
| Q1 FY2002 | 31 Mar 2002 | 0.59 | 1.24B | 2.10B |
| Q4 FY2001 | 31 Dec 2001 | 0.60 | 1.20B | 2.02B |
| Q3 FY2001 | 30 Sept 2001 | 0.65 | 1.21B | 1.86B |
| Q2 FY2001 | 30 Jun 2001 | 0.63 | 1.12B | 1.80B |
| Q1 FY2001 | 31 Mar 2001 | 0.46 | 908.00M | 1.96B |
| Q4 FY2000 | 31 Dec 2000 | 0.43 | 834.00M | 1.94B |
| Q3 FY2000 | 30 Sept 2000 | 0.44 | 860.00M | 1.93B |
| Q2 FY2000 | 30 Jun 2000 | 0.54 | 1.01B | 1.87B |
| Q1 FY2000 | 31 Mar 2000 | 0.66 | 1.18B | 1.78B |
| Q4 FY1999 | 31 Dec 1999 | 0.74 | 1.28B | 1.72B |
| Q3 FY1999 | 30 Sept 1999 | 0.75 | 1.32B | 1.75B |
| Q2 FY1999 | 30 Jun 1999 | 0.94 | 1.56B | 1.66B |
| Q1 FY1999 | 31 Mar 1999 | 2.48 | 2.29B | 921.00M |
| Q4 FY1998 | 31 Dec 1998 | 2.91 | 2.39B | 821.10M |
| Q3 FY1998 | 30 Sept 1998 | 3.64 | 2.64B | 725.10M |
| Q2 FY1998 | 30 Jun 1998 | 0.49 | 578.30M | 1.18B |
| Q1 FY1998 | 31 Mar 1998 | 0.54 | 572.60M | 1.06B |
| Q4 FY1997 | 31 Dec 1997 | 0.50 | 493.50M | 986.20M |
| Q3 FY1997 | 30 Sept 1997 | 0.41 | 415.80M | 1.02B |
| Q2 FY1997 | 30 Jun 1997 | 0.37 | 350.30M | 949.60M |
| Q1 FY1997 | 31 Mar 1997 | 0.28 | 270.00M | 970.60M |
| Q4 FY1996 | 31 Dec 1996 | 0.31 | 287.80M | 916.30M |
| Q3 FY1996 | 30 Sept 1996 | 0.27 | 226.00M | 831.10M |
| Q2 FY1996 | 30 Jun 1996 | 0.35 | 260.70M | 750.60M |
| Q1 FY1996 | 31 Mar 1996 | 0.20 | 156.30M | 795.50M |
| Q4 FY1995 | 31 Dec 1995 | 0.09 | 71.00M | 753.00M |
| Q3 FY1995 | 30 Sept 1995 | 0.06 | 37.70M | 642.60M |
| Q2 FY1995 | 30 Jun 1995 | 0.11 | 63.90M | 585.30M |
| Q1 FY1995 | 31 Mar 1995 | 0.14 | 75.40M | 527.30M |
| Q4 FY1994 | 31 Dec 1994 | 0.13 | 43.10M | 340.00M |
| Q3 FY1994 | 30 Sept 1994 | 0.13 | 39.70M | 315.90M |
| Q2 FY1994 | 30 Jun 1994 | 0.12 | 35.00M | 293.50M |
| Q1 FY1994 | 31 Mar 1994 | 0.12 | 32.00M | 273.80M |
| Q4 FY1993 | 31 Dec 1993 | 0.14 | 35.50M | 246.70M |
| Q3 FY1993 | 30 Sept 1993 | 0.16 | 35.50M | 224.90M |
| Q2 FY1993 | 30 Jun 1993 | 0.13 | 30.90M | 234.20M |
| Q1 FY1993 | 31 Mar 1993 | 0.10 | 26.40M | 264.20M |
| Q4 FY1992 | 31 Dec 1992 | 0.10 | 26.10M | 249.10M |
| Q3 FY1992 | 30 Sept 1992 | 0.12 | 27.70M | 234.20M |
| Q2 FY1992 | 30 Jun 1992 | 0.13 | 27.60M | 218.50M |
| Q1 FY1992 | 31 Mar 1992 | 0.52 | 42.70M | 82.40M |
| Q4 FY1991 | 31 Dec 1991 | 0.28 | 25.20M | 90.30M |
| Q3 FY1991 | 30 Sept 1991 | — | — | — |
| Q2 FY1991 | 30 Jun 1991 | — | — | — |
| Q1 FY1991 | 31 Mar 1991 | — | — | — |
Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.
See also:P/E ratio,Market cap,P/S ratio,ROE (return on equity),Current ratio,All ratios
Common questions about Boston Scientific's debt to equity
Source: Financial Modeling Prep
